Decentralized Trials & Research Alliance Appoints Jane Myles as Program Director

March 13, 2023 | Decentralized Trials & Research Alliance Appoints Jane Myles as Program Director

Decentralized Trials & Research Alliance appoints Jane Myles as Program Director, enhancing the global adoption of decentralized research to make research participation accessible for all.

Addition of key talent enhances the ability for members to realize the shared goal of making research participation accessible for all

SAN DIEGO, March 13th, 2023 -- 

The Decentralized Trials & Research Alliance (DTRA) today announced the appointment of Jane Myles as Program Director within the multi-stakeholder collaboration.  This critical addition to the organization will support the design and implementation of strategic initiatives meant to improve the global adoption of decentralized research.

Jane was a founding member of the DTRA Leadership Council and has been an active contributor to initiatives since the organization was launched in 2020.  She brings an expansive perspective and diverse background to DTRA with experience spanning international pharmaceutical and biotechnology sponsors, multinational CROs and in the technology sector. Most recently Jane served as Vice President for Clinical Trial Innovation at Curebase, a full-stack decentralized clinical trial technology and services provider.

 “This remains an exciting and dynamic time for decentralized research as global regulators release guidance, research sponsors stabilize their global operating models, and new solutions continue to enter the market,” said Amir Kalali, Co-Chair of DTRA.  “We are grateful to have Jane join the organization and help amplify the impact of decentralized research around the world.” 

“Jane is a proven leader with a track record blending vision with a commitment to getting work done,” shared Craig Lipset, Co-Chair of DTRA.  “Now is the ideal time for her skills to benefit the research community as DTRA members around the world collaborate to support research made accessible for all.”

The Decentralized Trials & Research Alliance (DTRA)a non-profit organization, was convened to enable collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research. It works to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research  methods. Follow DTRA on Twitter and LinkedIn for more information. 

Written By: DTRA